Ginsenoside Rg1 Alleviates Podocyte EMT Passage by Regulating AKT/GSK3 β/β-Catenin Pathway by Restoring Autophagic Activity.
Yimin ShiYan-Bin GaoTao WangXiaolei WangJiaxin HeJiayi XuBingjie WuYimeng LiPublished in: Evidence-based complementary and alternative medicine : eCAM (2020)
Ginsenoside Rg1 alleviated podocyte EMT by enhancing AKT/GSK3β/β-catenin pathway-mediated autophagy, indicating its therapeutic potential for DN and other glomerular diseases.β/β/.